Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 5589-5591, November 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López-Alarcón, L.
Right arrow Articles by Eboli, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López-Alarcón, L.
Right arrow Articles by Eboli, M.-L.

Oxidation of Reduced Cytosolic Nicotinamide Adenine Dinucleotide by the Malate-Aspartate Shuttle in the K-562 Human Leukemia Cell Line

Luisa López-Alarcón1 and Maria-Luisa Eboli

Servicio de Bioquimica Experimental, Clinica Puerta de Hierro, Facultad de Medicina, Universidad Autónoma, San Martin de Porres 4, 28035 Madrid, Spain [L. L-A.], and Istituto di Patologia Generale, Universitá Cattolica del Sacro Cuore, via Pineta Sacchetti 644, 00168 Roma, Italy [M-L. E.]

The activity of the malate-aspartate shuttle for the reoxidation of reduced cytosolic nicotinamide adenine dinucleotide (NADH) by mitochondria was studied in a line of human myeloid leukemia cells (K-562). The tumor cells showed mitochondrial reoxidation of cytosolic NADH, as evidenced by the accumulation of pyruvate, when incubated aerobically with L-lactate. The involvement of the respiratory chain in the reoxidation of cytosolic NADH was demonstrated by the action of rotenone, antimycin A, and oligomycin which strongly inhibited the formation of pyruvate from added L-lactate. Moreover, pyruvate production was greatly inhibited by the transaminase inhibitor, aminooxyacetate. Under glycolytic conditions, in the presence of aminooxyacetate, the rate of pyruvate production was also markedly inhibited, the rate of lactate accumulation was stimulated, and at 60 min the cytosolic NADH/nicotinamide adenine dinucleotide (NAD) ratio had increased progressively about 5-fold with respect to untreated cells. The maximal rate of the malate-aspartate shuttle has also been established by addition of arsenite to inhibit mitochondrial oxidation of the pyruvate formed from added L-lactate.

1 To whom requests for reprints should be addressed.

Received 4/24/86. Revised 7/22/86. Accepted 7/30/86.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. Salomon, D. W. Voehringer, L. A. Herzenberg, and C. Khosla
Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F0F1-ATPase
PNAS, December 19, 2000; 97(26): 14766 - 14771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mazurek, A. Michel, and E. Eigenbrodt
Effect of Extracellular AMP on Cell Proliferation and Metabolism of Breast Cancer Cell Lines with High and Low Glycolytic Rates
J. Biol. Chem., February 21, 1997; 272(8): 4941 - 4952.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.